Form 4 for AFRM Affirm Holdings, Inc.
Accepted 2026-09-03 17:15:25 ET · period of report 2026-09-01 · accession 0001628280-26-060528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-03 17:15 | 2026-09-01+ | AFRM | Adkins Katherine | CLO | M - OptEx | $20.20 | +93.9K | 194.1K | +94% | +$1.90M |
| DT | 2026-09-03 17:15 | 2026-09-01 | AFRM | Adkins Katherine | CLO | F - Tax | $69.94 | -4,795 | 152.4K | -3% | -$335.4K |
| DMT | 2026-09-03 17:15 | 2026-09-01+ | AFRM | Adkins Katherine | CLO | S - Sale+OE | $73.04 | -83.3K | 152.4K | -35% | -$6.09M |
| DMT | 2026-09-03 17:15 | 2026-09-01+ | AFRM | Adkins Katherine | CLO | M - OptEx | $0.00 | -93.9K | 43.9K | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-01 | M | A | 10,594 | $0.00 | 157,234 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-09-01 | F | D | 4,795 | $69.94 | 152,439 | D | — | — | (F1) Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the settlement of shares of Common Stock underlying the Reporting Person's restricted stock units that vested on September 1, 2026. |
| 3 | Common | Class A Common Stock | 2026-09-01 | M | A | 41,664 | $22.30 | 194,103 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
| 4 | Common | Class A Common Stock | 2026-09-01 | S | D | 23,765 | $70.13 | 170,338 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. (F3) Represents the weighted average sale price of the shares sold from $69.59 to $70.57 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Class A Common Stock | 2026-09-01 | S | D | 15,599 | $71.00 | 154,739 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. (F4) Represents the weighted average sale price of the shares sold from $70.59 to $71.58 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Class A Common Stock | 2026-09-01 | S | D | 2,300 | $71.87 | 152,439 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. (F5) Represents the weighted average sale price of the shares sold from $71.59 to $72.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Class A Common Stock | 2026-09-03 | M | A | 4,404 | $22.30 | 156,843 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
| 8 | Common | Class A Common Stock | 2026-09-03 | M | A | 37,260 | $23.35 | 194,103 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
| 9 | Common | Class A Common Stock | 2026-09-03 | S | D | 41,664 | $75.53 | 152,439 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. (F6) Represents the weighted average sale price of the shares sold from $75.00 to $75.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 1,622 | $0.00 | 12,976 | D | — · — to — | 1,622 Class A Common Stock | (F7) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F8) RSUs vest in equal quarterly installments for a period of three years beginning December 1, 2025, the vesting commencement date, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. (F8) RSUs vest in equal quarterly installments for a period of three years beginning December 1, 2025, the vesting commencement date, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. |
| 11 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 2,483 | $0.00 | 19,859 | D | — · — to — | 2,483 Class A Common Stock | (F7) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F9) The RSUs vest in 16 equal quarterly installments beginning September 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. (F9) The RSUs vest in 16 equal quarterly installments beginning September 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. |
| 12 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 5,086 | $0.00 | 20,343 | D | — · — to — | 5,086 Class A Common Stock | (F7) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F10) The RSUs vest in 16 equal quarterly installments beginning September 1, 2024, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. (F10) The RSUs vest in 16 equal quarterly installments beginning September 1, 2024, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. |
| 13 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 1,403 | $0.00 | 0 | D | — · — to — | 1,403 Class A Common Stock | (F7) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F11) The RSUs vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. (F11) The RSUs vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. |
| 14 | Derivative | Stock Option (Right to Buy) | 2026-09-01 | M | D | 41,664 | $0.00 | 12,084 | D | $22.30 · — to 2032-09-16 | 41,664 Class A Common Stock | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. (F12) The stock options vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |
| 15 | Derivative | Stock Option (Right to Buy) | 2026-09-03 | M | D | 4,404 | $0.00 | 7,680 | D | $22.30 · — to 2032-09-16 | 4,404 Class A Common Stock | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. (F12) The stock options vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |
| 16 | Derivative | Stock Option (Right to Buy) | 2026-09-03 | M | D | 37,260 | $0.00 | 43,874 | D | $23.35 · — to 2033-09-13 | 37,260 Class A Common Stock | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. (F13) The stock options vest in 48 equal monthly installments beginning October 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |